NewsRx

Search our medical news database

Haemophilus influenzae

Vaccine Credited with Near-Elimination of Hib Infection in U.S. Children

Published in Vaccine Weekly, March 30th, 1998

Incidence of Haemophilus influenzae type b (Hib) invasive disease in the United States has decreased by 98 percent in children four-years-old or younger since introduction of a conjugate vaccine against Hib in 1988, according to a U.S. government researcher.

Before 1985, one of every 200 children was at risk for Hib invasive disease. According to Dr. Kristine M. Bisgard, a researcher at the U.S. Centers for Disease Control and Prevention (CDC), this risk is "similar to the risk for poliomyelitis in the 1950s." Hib invasive disease was the most common cause of bacterial meningitis in children under age five, killing 5 percent and leaving 30 percent with...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


More Articles from Vaccine Weekly

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook